Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Kent A. Gifford Image

      Kent A. Gifford, Ph.D.

      Department of Radiation Physics, Division of Radiation Oncology

      Present Title & Affiliation

      Dual/Joint/Adjunct Appointment

      Professor, Radiation Physics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2004University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, US, Ph.D. in Medical Physics
      2001University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, US, M.S. in Biomedical Sciences
      1997Xavier University, Cincinnati, Ohio, US, BS in Physics

      Licenses & Certifications

      2007Medical Physicist License awarded by the Texas Medical Board
      2007American Board of Radiology

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Radiation Physics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021

      Assistant Professor, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2015

      Instructor, Department of Radiation Physics, UT M. D. Anderson Cancer Center, Houston, TX, 2004 - 2007

      Administrative Appointments/Responsibilities

      Residency Program Associate Director, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2017 - Present

      Other Professional Positions

      Faculty Senator, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2019

      Extramural Institutional Committee Activities

      Member, Midterm review committee (Julie Pollard-Larkin, Ph.D.), The University of Texas MD Anderson Cancer Center, 2023

      Member, Midterm review committee (Chester Wang, Ph.D.), The University of Texas MD Anderson Cancer Center, 2022

      Member, Radiation Oncology Technology Workstream, The University of Texas MD Anderson Cancer Center, 2020 - 2020

      Member, Breast treatment technology workstream, The University of Texas MD Anderson Cancer Center, 2020 - 2020

      Chair, Midterm Review Committee (Eun Young Han, Ph.D.), The University of Texas MD Anderson Cancer Center, 2018

      Member, DMP Clinical Curriculum Planning Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2017

      Member, DMP Steering Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Member, Time Driven Activity Based Costing analysis for breast cancer patients, The University of Texas MD Anderson Cancer Center, 2016 - 2016

      Member, Physics Focus Group- SafetyLink, The University of Texas MD Anderson Cancer Center, 2016

      Member, Midterm Review Committee (Julie Pollard, Ph.D.), The University of Texas MD Anderson Cancer Center, 2016

      Member, Midterm Review Committee (Melinda Chi, Ph.D.), The University of Texas MD Anderson Cancer Center, 2016

      Member, Breast planning flow mapping costing, The University of Texas MD Anderson Cancer Center, 2015

      Member, RCC-TMC Radiation Oncology Expansion Team, The University of Texas MD Anderson Cancer Center, 2015

      Member, Cancer Network Replacement and Expansion Space Planning committee, The University of Texas MD Anderson Cancer Center, 2015

      Member, ACB backfill committee, The University of Texas MD Anderson Cancer Center, 2015

      Chair, Medical Physics Residency Rotation Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Member, Medical Physics residency Steering Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Editorial Activities

      Section Editor, Journal of Applied Clinical Medical Physics, 2010 - Present

      Honors & Awards

      2018HDR LDR Prostate Workshop Scholarship, American Brachytherapy Society
      2004Aaron Blanchard award for best dissertation
      2003Outstanding Graduate Student Award, ACMP
      2002LAP Best Radiation Oncology Physics Paper, Journal of Applied Clinical Medical Physics
      1997Graduated Magna Cum-Laude, Xavier University

      Professional Memberships

      American Association of Physicists in Medicine

      2023

      American Association of Physicists in Medicine

      2023

      American Association of Physicists in Medicine

      2022 - Present

      American Association of Physicists in Medicine

      2022 - Present

      American Board of Radiology

      2021 - Present

      American Board of Radiology

      2016 - Present

      RTOG-NRG Oncology Medical Physics Subcommittee

      2013 - Present

      American Brachytherapy Society

      2013 - Present

      American College of Medical Physics (ACMP)

      2006 - Present

      American College of Medical Physics - Continuing Education Committee

      2006 - Present

      American Association of Physicists in Medicine (AAPM)

      1998 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2021. Radiation Dermatitis. Conference. Radiation Dermatitis. Austin, TX, US.

      National Presentations

      1. 2025. Evaluating the Performance and Limitations of an Automated Treatment Planning Tool for Intact Breast Radiotherapy across Diverse Patient Populations. Poster. 67th AAPM Annual Meeting & Exhibition. Washington, DC, US.
      2. 2023. Robustness of Chest Wall and Setup Uncertainties. Conference. Robustness of Chest Wall and Setup Uncertainties. New Orleans, LA, US.
      3. 2018. A comparison between dosimetric reporting quantities for APBI Brachytherapy: MBDCA and Monte Carlo. Conference. A comparison between dosimetric reporting quantities for APBI Brachytherapy: MBDCA and Monte Carlo. Nashville, TN, US.
      4. 2018. Comparison of two commercially available model based dose calculation algorithms and TG-43 for APBI brachytherapy. Conference. Comparison of two commercially available model based dose calculation algorithms and TG-43 for APBI brachytherapy. San Francisco, CA, US.
      5. 2016. Self-held Breath Control with Respiratory Monitoring and Feedback Guidance. Conference. Self-held Breath Control with Respiratory Monitoring and Feedback Guidance. Washington, DC, US.
      6. 2014. Dosimetric Evaluation of a Novel CT/MR Compatible Fletcher Applicator for Intracavitary Brachytherapy of the Cervix Uteri. Conference. Dosimetric Evaluation of a Novel CT/MR Compatible Fletcher Applicator for Intracavitary Brachytherapy of the Cervix Uteri. Austin, TX, US.
      7. 2014. APBI Brachytherapy Treatment Planning: The Impact of Heterogeneous Dose Calculations. Conference. APBI Brachytherapy Treatment Planning: The Impact of Heterogeneous Dose Calculations. Austin, TX, US.
      8. 2014. Dosimetric Comparison Between a Commercial Collapsed Cone Algorithm and the TG-43 Method for Accelerated Partial Breast Irradiation Brachytherapy. Conference. Dosimetric Comparison Between a Commercial Collapsed Cone Algorithm and the TG-43 Method for Accelerated Partial Breast Irradiation Brachytherapy. San Diego, CA, US.
      9. 2013. Dosimetric Verification of a Commercial Brachytherapy Treatment Planning System for a Single Entry APBI Hybrid Catheter by PRESAGE and Radiochromic Film. Conference. Dosimetric Verification of a Commercial Brachytherapy Treatment Planning System for a Single Entry APBI Hybrid Catheter by PRESAGE and Radiochromic Film. New Orleans, LA, US.
      10. 2013. APBI: Rationale, techniques, and pitfalls. Conference. APBI: Rationale, techniques, and pitfalls. Montgomery, TX, US.
      11. 2012. Skin sequelae from APBI brachytherapy treatment, incidence, and mitigation strategies. Conference. 3rd Advances in Oncology. Houston, TX, US.
      12. 2011. APBI Brachytherapy: The perspective of a physicist. Conference. SWAAPM. Dallas, TX, US.
      13. 2011. On the feasibility of treating to a 1.5 cm PTV with a commercial single-entry hybrid applicator. Conference. ABS. San Diego, CA, US.
      14. 2006. Calculation of the dose distribution around a high dose rate Ir-192 brachytherapy source via a multi-group discrete ordinates method. Conference. AAPM Meeting, US.
      15. 2006. Calculation of the Dose Distribution Around a High Dose Rate Ir-192 Brachytherapy Source via a Multi-group Discrete Ordinates Method. Conference. AAPM Meeting, US.
      16. 2004. Verification of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with Normoxic Polymer Gel Dosimetry. Conference. Third International Conference on Gel Dosimetry, US.
      17. 2004. Verification of Monte Carlo Calculations around a Fletcher Suit Delclos Ovoid with Radiochromic Film and Normoxic Polymer Gel Dosimetry. Conference. AAPM Meeting, US.
      18. 2001. A Measured Data Set for Photon Dose-Calculation Verification. Conference. AAPM Meeting, US.

      International Presentations

      1. 2020. Cosmic Rays to Casinos: Transitioning to RayStation electrons. Conference. RaySearch Laboratories, SE.
      2. 2013. PRESAGE® dosimeter for quality assurance. Conference. PRESAGE® dosimeter for quality assurance, SG.
      3. 2013. PRESAGE dosimeter as a 3D dosimeter for breast IMRT: a feasibility study. Conference. PRESAGE dosimeter as a 3D dosimeter for breast IMRT: a feasibility study. Brighton, GB.
      4. 2007. Attila: A Deterministic Transport Code Applied to Radiotherapy Calculations. Conference. 9th Biennial ESTRO Meeting, ES.

      Formal Peers

      1. 2013. Brachytherapy: What, Where, Why, How... Invited. Houston, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2012 - 2015
      Title:Startup funds
      Funding Source:The University of Texas M.D. Anderson Cancer Center
      Role:PI
      Date: 2007 - 2009
      Title:Deterministic Radiotherapy Dose Calculation Method
      Funding Source:SBIR with Transpire, Inc
      Role:Co-I
      Date: 2004 - 2005
      Title:Dosimetric Evaluation of Pulsed Dose-rate Brachytherapy for Gynecological Cancer Treatment: A Monte Carlo Study
      Funding Source:SRA from Nucletron
      Role:Co-I
      ID:AI12345-05

      Selected Publications

      Peer-Reviewed Articles

      1. Baroudi, H, Che Fru, L, Schofield, D, Roniger, DL, Nguyen, C, Hancock, D, Chung, CV, Beadle, BM, Gifford, KA, Netherton, T, Niedzielski, JS, Melancon, AD, Muruganandham, M, Khan, M, Shaitelman, SF, Shete, S, Murina, P, Venencia, D, Thengumpallil, S, Vrieling, C, Zhang, J, Mitchell, MP, Court, LE. An automated treatment planning portfolio for whole breast radiotherapy. Medical physics 52(3):1779-1788, 2025. e-Pub 2025. PMID: 39699058.
      2. Iqbal K, Ibbott GS, Lafratta R, Gifford KA, Akram M, Buzdar S. Dosimetric feasibility of an anthropomorphic three-dimensional PRESAGE® dosimeter for verification of single entry hybrid catheter accelerated partial breast brachytherapy. Journal of Radiotherapy in Practice 17(4):403-410, 2019. e-Pub 2019.
      3. Iqbal K, Shamsi Q, Gifford KA, Anum S, Buzdar S. A dosimetric analysis of proton beam therapy using different snouts. Journal of Radiotherapy in Practice 18(2):180-185. e-Pub 2019.
      4. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol 36(24):2538-2544, 2018. e-Pub 2018. PMID: 29989857.
      5. Iqbal K, Ibbott GS, Lafratta R, Gifford KA, Buzdar S. Dosimetric characterisation of anthropomorphic PRESAGE® dosimeter and EBT2 film for partial breast radiotherapy. Journal of Radiotherapy in Practice 17(1):96-103, 2018. e-Pub 2018.
      6. Thrower SL, Shaitelman SF, Bloom E, Salehpour M, Gifford K. Comparison of Dose Distributions With TG-43 and Collapsed Cone Convolution Algorithms Applied to Accelerated Partial Breast Irradiation Patient Plans. Int J Radiat Oncol Biol Phys 95(5):1520-6, 2016. e-Pub 2016. PMID: 27315666.
      7. Iqbal K, Gifford KA, Ibbott G, Grant RL, Buzdar S. Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study. J Appl Clin Med Phys 15(1):4531, 2014. e-Pub 2014. PMID: 24423854.
      8. Iqbal K, Gifford KA, Ibbott G, Grant RL, Buzdar SA. Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study. J Appl Clin Med Phys 15(1):363-374, 2014. e-Pub 2014. PMID: 28297232.
      9. Iqbal K, Gillin M, Summers PA, Dhanesar S, Gifford KA, Buzdar SA. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom. Br J Radiol 86(1031):20130390, 2013. e-Pub 2013. PMID: 24049129.
      10. Gifford KA, Pacha O, Hebert AA, Nelson CL, Kirsner SM, Ballo MT, Bloom ES. A new paradigm for calculating skin dose. Brachytherapy 12(2):114-9, 2013. e-Pub 2013. PMID: 22884255.
      11. Gifford KA, Nelson CL, Kirsner SM, Kisling KD, Ballo MT, Bloom ES. On the feasibility of treating to a 1.5 cm PTV with a commercial single-entry hybrid applicator in APBI breast brachytherapy. J Contemp Brachytherapy 4(1):29-33, 2012. e-Pub 2012. PMID: 23346137.
      12. Iqbal K, Isa M, Buzdar SA, Gifford KA, Afzal M. Treatment planning evaluation of sliding window and multiple static segments technique in intensity modulated radiotherapy. Rep Pract Oncol Radiother 18(2):101-106, 2012. e-Pub 2012. PMID: 24416536.
      13. Bloom ES, Kirsner S, Mason BE, Nelson CL, Hunt KK, Baumann DP, Gifford KA. Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation. Brachytherapy 10(3):178-83, 2011. e-Pub 2011. PMID: 20719576.
      14. Gifford KA, Wareing TA, Failla G, Horton JL, Eifel PJ, Mourtada F. Comparison of a 3-D Multi-Group SN Particle Transport Code with Monte Carlo for Intracavitary Brachytherapy of the Cervix Uteri. J Appl Clin Med Phys 11(1):3103, 2009. e-Pub 2009. PMID: 20160682.
      15. Price MJ, Jackson EF, Gifford KA, Eifel PJ, Mourtada F. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging. Med Phys 36(12):5515-24, 2009. e-Pub 2009. PMID: 20095264.
      16. Price MJ, Gifford KA, Horton JL, Eifel PJ, Gillin MT, Lawyer AA, Mourtada F. Monte Carlo Model for a Prototype CT-compatible, Anatomically Adaptive, Shielded Intracavitary Brachytherapy Applicator for the Treatment of Cervical Cancer. Med Phys 36(9):4147-55, 2009. e-Pub 2009. PMID: 19810488.
      17. Vassiliev ON, Wareing TA, Davis IM, McGhee J, Barnett D, Horton JL, Gifford K, Failla G, Titt U, Mourtada F. Feasibility of a multigroup deterministic solution method for three-dimensional radiotherapy dose calculations. Int J Radiat Oncol Biol Phys 72(1):220-7, 2008. e-Pub 2008. PMID: 18722273.
      18. Gifford KA, Price MJ, Horton JL, Wareing TA, Mourtada F. Optimization of deterministic transport parameters for the calculation of the dose distribution around a high dose-rate 192Ir brachytherapy source. Med Phys 35(6):2279-85, 2008. e-Pub 2008. PMID: 18649459.
      19. Mourtada F, Gifford KA, Berner PA, Horton JL, Price MJ, Lawyer AA, Eifel PJ. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids. Med Dosim 32(3):181-7, 2007. e-Pub 2007. PMID: 17707197.
      20. Kendall RL, Gifford KA, Kirsner SM. The impact of peak-kilovoltage settings on heterogeneity-corrected photon-beam treatment plans. Radiother Oncol 81(2):206-8, 2006. e-Pub 2006. PMID: 17069913.
      21. Price MJ, Gifford KA, Horton J, Lawyer A, Eifel P, Mourtada F. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study. Phys Med Biol 51(16):4083-94, 2006. e-Pub 2006. PMID: 16885626.
      22. Gifford KA, Horton JL, Wareing TA, Failla G, Mourtada F. Comparison of a finite-element multigroup discrete-ordinates code with Monte Carlo for radiotherapy calculations. Phys Med Biol 51(9):2253-65, 2006. e-Pub 2006. PMID: 16625040.
      23. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study. Phys Med Biol 50(21):5075-87, 2005. e-Pub 2005. PMID: 16237242.
      24. Gifford KA, Mourtada F, Cho SH, Lawyer A, Horton JL. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator. Radiother Oncol 77(2):210-5, 2005. e-Pub 2005. PMID: 16216363.
      25. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 2005. e-Pub 2005. PMID: 16168853.
      26. Gifford KA, Horton JL, Jackson EF, Steger TR, Heard MP, Mourtada F, Lawyer AA, Ibbott GS. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry. Med Phys 32(7):2288-94, 2005. e-Pub 2005. PMID: 16121584.
      27. Gifford KA, Horton JL, Steger TR, Heard MP, Jackson EF, Ibbott GS. Verification of Monte Carlo Calculations Around a Fletcher Suit Delclos Ovoid with Normoxic Polymer Gel Dosimetry. J Phys 3:217-220, 2004. e-Pub 2004.
      28. Gifford KA, Followill DS, Liu HH, Starkschall G. Verification of the accuracy of a photon dose-calculation algorithm. J Appl Clin Med Phys 3(1):26-45, 2002. e-Pub 2002. PMID: 11818002.

      Other Articles

      1. Melancon AD, Gifford KA, Reiazi,R, Court, L, Che Fru, L, Muruganandham,M, Salehpour, MR, Zhao,Y, Schofield,D, Schueler, E, Mitchell, M Tissue Equivalence of Brass Mesh Bolus and Its Efficacy In Mitigating Loss of Skin Dose In the Presence of Skin–Bolus Air Gaps.
      2. Gifford KA, Muruganandham M, Che Fru L, Baroudi H, Evans S, Nguyen C, Netherton T, Afifi S, Niedzielski JS, Melancon A, Mohamad I, Shaitelman SF, Shaw W, Shete S, Shulman A, Smith B, Murina P, Venencia D, Thengumpallil S, Vrieling C, Mitchell MP, Court LE Evaluating the Performance and Limitations of an Automated Treatment Planning Tool for Intact Breast Radiotherapy across Diverse Patient Populations.

      Abstracts

      1. Seua C, Shahid K, Dwivedi S, Baker J, Gifford KA, Mitchell M, Bonetati A. Robustness of Chest Wall Plans and Setup Uncertainties. Med Dosim. e-Pub 2023.
      2. Galindo E, Lauck K, Gifford K, Hebert A. Prevention and Treatment of Breast Radiation Dermatitis: Beyond Topical Therapies, 2021. e-Pub 2021.
      3. Gifford KA, Fonseca GP, Thrower S, Verhaegen F. Comparison of Two Commercially Available Model Based Dose Calculation Algorithms and TG-43 for APBI Brachytherapy. Brachytherapy 17(4):S32. e-Pub 2018.
      4. Fonseca GP, Verhaegen F, Thrower S, Gifford KA. A comparison between dosimetric reporting quantities for APBI brachytherapy: MBDCA and Monte Carlo. Med. Phys 45(6):495. e-Pub 2018.
      5. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford KA, Gaffney DK, Small Jr W, Thompson S, Doncals DE, Cantuaria GH, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. A phase III randomized trial comparing patient reported toxicity and quality of life (QOL) during pelvic IMRT as compared to conventional Ratiotherapy. Int. J. Radiat. Oncol. Biol. Phys 96(2):S3. e-Pub 2016.
      6. Cai CY, Calhoun JD, Kanke J, Melancon AD, Collado D, Gifford K, Semien K, Potocsny N, Stauder MC, Guzman AB, Randolph CL, Sobremonte A, Marsh GD, Woodward WA, Feeley TW, Shaitelman SF. Defining Cost as a First Step to Determining the Value of Radiation Services Provided: Utilizing Time-Driven Activity-Based Costing to Ascertain True Costs in Breast Cancer Radiation Treatment Planning. Int. J. Radiat. Biol. Phys 96(2):E400, 2016. e-Pub 2016.
      7. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Jr W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko B, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Bruner D. A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. Int. J. Radiat. Biol. Phys 96(2):S3, 2016. e-Pub 2016.
      8. Prajapati S, Yan Y, Gifford K. Development of a Linac Monte Carlo Model to Calculate Surface Dose. Med. Phys 43(6):3548, 2016. e-Pub 2016.
      9. Han T, Smith B, Salehpour M, Gifford KA. Verification of 3D Surface Registration Between Stereograms and CT images. Med. Phys 41(6):205. e-Pub 2014.
      10. Gifford KA, Han T, Mourtada F, Eifel PJ. Dosimetric Evaluation of a Novel CT/MR Compatible Fletcher Applicator for Intracavitary Brachytherapy of the Cervix Uteri. Med. Phys 41(6):388. e-Pub 2014.
      11. Loupot S, Han T, Salehpour M, Gifford KA. APBI Brachytherapy Treatment Planning: The Impact of Heterogeneous Dose Calculations. Med. Phys 41:388. e-Pub 2014.
      12. Han T, Salehpour MR, Gifford KA. Dosimetric Comparison Between a Commercial Collapsed Cone Algorithm and the TG-43 Method for Accelerated Partial Breast Irradiation Brachytherapy. Brachytherapy 13(S1):S50-51, 2014. e-Pub 2014.
      13. Iqbal K, Gifford KA, Grant RL, Buzdar SA, Ibbott GS. Dosimetric Verification of a Commercial Brachytherapy Treatment Planning System for a Single Entry APBI Hybrid Catheter Device by PRESAGE® and Radiochromic Film. Brachytherapy 12:S21, 2013. e-Pub 2013.
      14. Iqbal K, Gifford KA, Ibbott GS, Buzdar SA. Investigation of the accuracy of an anthropomorphic PRESAGE® dosimeter in the dosimetric evaluation of breast IMRT. Medical physics International Journal 1(2):485, 2013. e-Pub 2013.
      15. Kemp J, Price MJ, Gifford KA, Parker BC, Mason B, Rechner L, Neck D, Ferachi K, Gibbons J, Matthews K. Facilitating 3D Image Guided Treatment Planning of Shielded Tandem and Ovoid-based, Gynecological Brachytherapy Utilizing MVCT. Int J Radiat Oncol Biol Phys 84(3):s868-9, 2012. e-Pub 2012.
      16. Vredevoogd K, Ibbott G, Gillin M, Sahoo N, Kry S, Gifford K, Maryanski M. SU-E-T-103: Three-Dimensional Measurements of Dose and LET from a Proton Beam via Polymer Gel Dosimetry. Med Phys 39(6Part11):3726, 2012. e-Pub 2012. PMID: 28517123.
      17. Nelson C, Gifford K, Kisling K, Kirsner S. SU-E-T-215: A Technique for Treating Patients outside the Mosaiq R&V System for TrueBeam Users (or 4DTC). Med Phys 39(6Part13):3752-3753, 2012. e-Pub 2012. PMID: 28517332.
      18. Nelson C, Gifford K, Kisling K, Bloom E, Kirsner S. SU-E-T-186: An Automated Quality Assurance Tool for HDR Treatment Planning. Med Phys 39(6Part12):3745, 2012. e-Pub 2012. PMID: 28517816.
      19. Nelson CL, Gifford KA, Shah S, Kirsner SM, Bloom ES, Arzu IY. Chest Wall Reproducibility during Breath Hold Treatment for Left Sided Breast Cancers Measured using CINE Images, 2012. e-Pub 2012.
      20. Bloom ES, Gifford KA, Kirsner SM, Kisling K, Nelson CL. The importance of multidisciplinary collaboration between surgeon and radiation oncologists for optimal placement of single-entry brachytherapy catheters for accelerated partial breast irradiation. The American Society of Breast Surgeons Meeting, 2012. e-Pub 2012.
      21. Bloom ES, Whitsell T, Kirsner SM, Nelson CL, Mason B, Gifford KA. Can PTV eval be used as surrogate for normal breast tissue in the determination of v150 and v200?. Radiother Oncol 103:S50, 2012. e-Pub 2012.
      22. Gifford KA, Bloom ES, Kirsner SM, Nelson CL, Mason BE, Hebert AA. Estimation and Application of a Consensus Breast Epidermal Thickness for Radiation Treatment Planning. Advances in Oncology- Clinical Science to Clinical Practice, 2011. e-Pub 2011.
      23. Nelson CL, Gifford KA, Kirsner SM, Shah S, Bloom ES, Mason BE, Arzu IY. Analysis of Intra‐Fraction Chest Wall Motion during Breath Hold Treatment for Left Sided Breast Cancer. Med Phys 38:3476, 2011. e-Pub 2011.
      24. Gifford KA, Hunter L, Ballo MT, Kirsner SM, Mason BE, Nelson CL. Verification of the Accuracy of a Commercial Pre‐Treatment IMRT QA Software. Med Phys 38:3586, 2011. e-Pub 2011.
      25. Gifford KA, Nelson CL, Kirsner SM, Bloom ES. On the Feasibility of Treating to a 1.5 cm PTV for Accelerated Partial Breast Brachytherapy With a Commercial Single Entry Hybrid Applicator. Brachytherapy 10:S43, 2011. e-Pub 2011.
      26. Pollard JM, Kirsner SM, Mason BE, Nelson CL, Bloom ES, Gifford KA. Evaluation of Two Brachytherapy Planning Methods for Accelerated Partial Breast Irradiation using MammoSite. Int. J. Rad. Onc. Biol. Phys 78(3):Page S840, 2010. e-Pub 2010.
      27. Mourtada F, Pung N, Gifford KA, Lawyer AA, Wendt R, White A, Eifel PJ. A Conversion Method of Low Dose Rate to Pulsed Dose Rate Intracavitary Brachytherapy Prescription for the Treatment of Cervical Carcinoma. Med Phys 36:2424, 2009. e-Pub 2009.
      28. Nelson CL, Kirsner SM, Gifford KA. On the Dosimetric Differences Between Single Dwell and Multiple-Dwell Accelerated Partial Breast Brachytherapy Plans Delivered with a Single Catheter Spherical Balloon. Med Phys 36:2535, 2009. e-Pub 2009.
      29. Gifford KA. Attila: A Determininstic Transport Code Applied to Radiotherapy Calculations. European Society for Therapeutic Radiology and Oncology 84, Supplement 1, 2007. e-Pub 2007.
      30. Mourtada F, Price M, Gifford K, Horton J, Lawyer A, Jhingran A, Eifel P. A conversion method of low-dose-rate tandem and ovoid prescription to pulsed-dose-rate for the Plato treatment planning system, 2007. e-Pub 2007.
      31. Gifford KA, Kirsner S, Horton J, Wareing T, Mourtada F. Calculation of the dose distribution around commercially available 125I brachytherapy source via multi-group discrete ordinates methods. Med Phys 34(7):2550, 2007. e-Pub 2007.
      32. Gifford KA, Price MJ, Failla G, Wareing TA, Horton JL, Mourtada F. Calculation of the Dose Distribution Around a High Dose Rate Ir-192 Brachytherapy Source via a Multi-group Discrete Ordinates Method. Med Phys 33(7):2237, 2006. e-Pub 2006.
      33. Price MJ, Gifford KA, Horton JH, Eifel PJ, Mourtada. Capabilities of a CT-Suitable, Patient-Adaptive HDR/PDR Intracavitary Brachytherapy Applicator for the Treatment of Cervical Cancer. Med Phys 33:2205, 2006. e-Pub 2006.
      34. Price MJ, Mourtada F, Gifford KA, Horton JL, Eifel PJ. CT Protocol for Artifact-free Imaging of a Novel Intracavitary Brachytherapy Cervical Applicator. Int J Radiat Oncol Biol Phys 63(3):S701, 2006. e-Pub 2006.
      35. Gifford KA, Horton JL, Failla G, Barnett D, McGhee J, Wareing TA, Eifel PJ, Mourtada F. Comparison of a 3D Multi-group Sn Particle Transport Code with Monte Carlo for Intracavitary Brachytherapy of the Cervix Uteri. Med. Phys 32(6):1949, 2005. e-Pub 2005.
      36. Price MJ, Gifford KA, Horton JL, Eifel PJ, Lawyer AA, Jhingran A, Mourtada F. Comparison of LDR to PDR dose distributions: A Monte Carlo Study. Med. Phys 32(6):2098, 2005. e-Pub 2005.
      37. Mourtada F, Wareing T, Horton J, McGhee J, Barnett A, Gifford KA, Failla G, Mohan R. A Deterministic Dose Calculation Method Applied to the Dosimetry of Shielded Intracavitary Brachytherapy Applicators. Med. Phys 31(6):1807, 2004. e-Pub 2004.
      38. Gifford KA, Horton JL, Jackson EF, Steger TR, Heard MP, Mourtada F, Lawyer A, Ibbott GS. Verification of Monte Carlo Calculations around a Fletcher Suite Delclos Ovoid with Radiochromic Film and Normoxic Polymer Gel Dosimetry. Med Phys 31(6):1808, 2004. e-Pub 2004.
      39. Gifford KA, Horton JL, Steger TR, Heard MP, Jackson EF, Ibbott GS. Verification of Monte Carlo calculations around a Fletcher Suite Delclos ovoid with Normoxic Polymer Gel Dosimetry. J Phys Conf Ser 3:217, 2004. e-Pub 2004.
      40. Gifford KA, Lawyer AA, Jhingran A, Eifel PJ, Horton JL. Monte Carlo calculations around a Commercial Gynecological Applicator. Med. Phys 30(8):470, 2003. e-Pub 2003.
      41. Gifford KA, Starkschall G, Liu HH. Verification of a Commercial Photon-Dose-Calculation algorithm. Med. Phys 28:1193, 2001. e-Pub 2001.

      Book Chapters

      1. Schofield, D, Simiele, SJ, Sohn, JJ, Wong, J, Gifford, KA. The Role of Gas-Filled Detectors in Brachytherapy. In: Radiation Detectors and Methods in Medicine, 373-383, 2026.
      2. Brezovich I, Caggiano A, Gifford KA. Basic Science of Radiation Oncology. In: Fundamentals of Radiation Oncology. 3rd. Elsevier, 2019.
      3. Brezovich I, Caggiano A, Gifford KA. Radiation Protection for Radiation Oncology. In: Fundamentals of Radiation Oncology. 3rd. Elsevier, 2019.
      4. Brezovich I, Caggiano A, Gifford KA. Radiation Physics, Dosimetry, and Treatment Planning. In: Fundamentals of Radiation Oncology. 4th. Elsevier.
      5. Brezovich I, Caggiano A, Gifford KA. Radiation Protection and Safety. In: Fundamentals of Radiation Oncology. 4th. Elsevier.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 28, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top